CD8A and neoplasm: Analysis of longitudinal peripheral blood specimens by flow cytometry revealed higher frequency of EOMES+CD8+ T cells in posttreatment samples of responding patients, suggesting CD8+ T cells expressing EOMES could contribute to tumour regression.